On September 2, 2021 Instil Bio, Inc. ("Instil") (NASDAQ: TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, reported that company management will participate in two upcoming investor conferences in September (Press release, Instil Bio, SEP 2, 2021, View Source [SID1234587175]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Morgan Stanley 19th Annual Global Healthcare Conference
Fireside Chat: Thursday, September 9 at 2:00 p.m. ET

Baird’s 2021 Virtual Global Healthcare Conference
Company Presentation: Tuesday, September 14 at 5:30 p.m. ET

A live webcast, if recorded, of each presentation can be accessed under "News & Events" in the Investors section of the Company’s website at www.instilbio.com. The archived webcast will be available on the Company’s website shortly after the event.

On September 2, 2021 ChemoCentryx, Inc., (Nasdaq: CCXI), reported that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences (Press release, ChemoCentryx, SEP 2, 2021, View Source [SID1234587194]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Virtual Wells Fargo Healthcare Conference
Fireside Chat Thursday, September 9 at 4:40 p.m. Eastern Time
H.C. Wainwright 23rd Annual Global Investment Conference
On-demand presentation available beginning Monday, September 13 at 7:00 a.m. Eastern Time
Live audio webcasts of the Wells Fargo fireside chat, as well as the on-demand H.C. Wainwright presentation can be accessed through the Investors section of the Company’s website at www.ChemoCentryx.com. Replays of both the Wells Fargo and H.C. Wainwright presentations will be available on the Company’s website for two weeks following the respective presentation dates.

On September 2, 2021 Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) reported that management will present a company overview at the following virtual investor conferences (Press release, Ionis Pharmaceuticals, SEP 2, 2021, View Source [SID1234587210]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021
Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021
Bank of America Global Healthcare Conference 2021 on Wednesday, September 15, 2021
The above listed dates are subject to change. Details on presentation times or changes to presentation dates can be found on the Company’s website. Please check www.ionispharma.com for the latest information.

A live webcast of the presentations will be available on the Investors & Media section of the Ionis website. The replays will be available within 48 hours and will be archived for a limited time.

On September 2, 2021 Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, reported that Ayala management will participate in two upcoming virtual investor conferences in September (Press release, Ayala Pharmaceuticals, SEP 2, 2021, View Source [SID1234593998]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investor Conference: Corporate Presentation available on-demand starting Monday, September 13, 2021 at 7:00 am ET.
Citi’s 16th Annual Biopharma Virtual Conference: Management will participate in investor meetings on Thursday, September 9, 2021.
A webcast of the H.C. Wainwright 23rd Annual Global Investor Conference presentation may be accessed by visiting the Events & Presentations section of Ayala’s website at ir.ayalapharma.com. An archived replay of the webcast will be available on the website for approximately 90 days following the presentation.

On September 2, 2021 Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, reported it will participate in three upcoming conferences (Press release, Delcath Systems, SEP 2, 2021, View Source [SID1234595224]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021

Presentation Date and Time: On-demand beginning 9/13/2021 at 7:00 AM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23

Presentation Date and Time: 9/21/2021 12:25 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
Cantor Fitzgerald Healthcare Conference: September 27th to 30th, 2021

Presentation Date and Time: 9/29/2021 4:40 PM (ET)
Webcast: View Source
Management will also host 1×1 investor meetings during the conference.
To learn more or to schedule a one-on-one meeting with management, please contact your conference representative or [email protected].